ID   DCXR_HUMAN              Reviewed;         244 AA.
AC   Q7Z4W1; Q9BTZ3; Q9UHY9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=L-xylulose reductase;
DE            Short=XR;
DE            EC=1.1.1.10;
DE   AltName: Full=Carbonyl reductase II;
DE   AltName: Full=Dicarbonyl/L-xylulose reductase;
DE   AltName: Full=Kidney dicarbonyl reductase;
DE            Short=kiDCR;
DE   AltName: Full=Short chain dehydrogenase/reductase family 20C member 1;
DE   AltName: Full=Sperm surface protein P34H;
GN   Name=DCXR; Synonyms=SDR20C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Epididymis;
RX   PubMed=10385429; DOI=10.1210/endo.140.7.6791;
RA   Legare C., Gaudreault C., St Jacques S., Sullivan R.;
RT   "P34H sperm protein is preferentially expressed by the human corpus
RT   epididymidis.";
RL   Endocrinology 140:3318-3327(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], ENZYME ACTIVITY, TISSUE SPECIFICITY, AND
RP   INVOLVEMENT IN PNTSU.
RX   PubMed=11882650; DOI=10.1074/jbc.M110703200;
RA   Nakagawa J., Ishikura S., Asami J., Isaji T., Usami N., Hara A.,
RA   Sakurai T., Tsuritani K., Oda K., Takahashi M., Yoshimoto M.,
RA   Otsuka N., Kitamura K.;
RT   "Molecular characterization of mammalian dicarbonyl/L-xylulose
RT   reductase and its localization in kidney.";
RL   J. Biol. Chem. 277:17883-17891(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Epididymis, Liver, and Testis;
RX   PubMed=12680326;
RA   Xia X.Y., Xu X.F., Gao Y., Huang Y.F.;
RT   "Molecular cloning of human sperm surface protein P34H gene and semi-
RT   quantitative analysis of its expression in testis and epididymidis.";
RL   Zhonghua Nan Ke Xue 9:24-27(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adrenal gland;
RA   Huang C., Li Y., Wu T., Peng Y., Gu Y., Zhang L., Jiang C., Zhang C.,
RA   Han Z., Wang Y., Chen Z., Fu G.;
RT   "A novel gene expressed in the human adrenal gland.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liu Q., Yu L., Zhao S.Y.;
RT   "Cloning and characterization of a new human cDNA of carbonyl
RT   reductase.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-8, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   POSSIBLE INVOLVEMENT IN PNTSU.
RX   PubMed=4392213; DOI=10.1056/NEJM197004162821604;
RA   Wang Y.M., Van Eys J.;
RT   "The enzymatic defect in essential pentosuria.";
RL   N. Engl. J. Med. 282:892-896(1970).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INVOLVEMENT IN PNTSU.
RX   PubMed=22042873; DOI=10.1073/pnas.1115888108;
RA   Pierce S.B., Spurrell C.H., Mandell J.B., Lee M.K., Zeligson S.,
RA   Bereman M.S., Stray S.M., Fokstuen S., MacCoss M.J., Levy-Lahad E.,
RA   King M.C., Motulsky A.G.;
RT   "Garrod's fourth inborn error of metabolism solved by the
RT   identification of mutations causing pentosuria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:18313-18317(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS).
RX   PubMed=12136162; DOI=10.1107/S0907444902008156;
RA   El-Kabbani O., Chung R.P.-T., Ishikura S., Usami N., Nakagawa J.,
RA   Hara A.;
RT   "Crystallization and preliminary crystallographic analysis of human L-
RT   xylulose reductase.";
RL   Acta Crystallogr. D 58:1379-1380(2002).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SUBSTRATE, AND MUTAGENESIS OF ASN-107.
RX   PubMed=15103634; DOI=10.1002/prot.20047;
RA   El-Kabbani O., Ishikura S., Darmanin C., Carbone V., Chung R.P.-T.,
RA   Usami N., Hara A.;
RT   "Crystal structure of human L-xylulose reductase holoenzyme: probing
RT   the role of Asn107 with site-directed mutagenesis.";
RL   Proteins 55:724-732(2004).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of several
CC       pentoses, tetroses, trioses, alpha-dicarbonyl compounds and L-
CC       xylulose. Participates in the uronate cycle of glucose metabolism.
CC       May play a role in the water absorption and cellular
CC       osmoregulation in the proximal renal tubules by producing xylitol,
CC       an osmolyte, thereby preventing osmolytic stress from occurring in
CC       the renal tubules.
CC   -!- CATALYTIC ACTIVITY: Xylitol + NADP(+) = L-xylulose + NADPH.
CC       {ECO:0000269|PubMed:11882650}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15103634}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1044712, EBI-1044712;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Note=Probably recruited to membranes via an
CC       interaction with phosphatidylinositol. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, liver and
CC       epididymis. In the epididymis, it is mainly expressed in the
CC       proximal and distal sections of the corpus region. Weakly or not
CC       expressed in brain, lung, heart, spleen and testis.
CC       {ECO:0000269|PubMed:10385429, ECO:0000269|PubMed:11882650}.
CC   -!- DISEASE: Pentosuria (PNTSU) [MIM:260800]: An inborn error of
CC       metabolism characterized by excessive urinary excretion of L-
CC       xylulose. {ECO:0000269|PubMed:11882650,
CC       ECO:0000269|PubMed:22042873, ECO:0000269|PubMed:4392213}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB013846; BAB64299.1; -; mRNA.
DR   EMBL; AF515623; AAN59786.1; -; mRNA.
DR   EMBL; AF515624; AAO15991.1; -; mRNA.
DR   EMBL; AF515625; AAM54026.1; -; mRNA.
DR   EMBL; AF113123; AAF14864.1; -; mRNA.
DR   EMBL; AF139841; AAP97273.1; -; mRNA.
DR   EMBL; BT006881; AAP35527.1; -; mRNA.
DR   EMBL; BC001470; AAH01470.1; -; mRNA.
DR   EMBL; BC003018; AAH03018.1; -; mRNA.
DR   CCDS; CCDS11799.1; -.
DR   RefSeq; NP_001182147.1; NM_001195218.1.
DR   RefSeq; NP_057370.1; NM_016286.3.
DR   UniGene; Hs.9857; -.
DR   PDB; 1PR9; X-ray; 1.96 A; A/B=1-244.
DR   PDB; 1WNT; X-ray; 2.30 A; A/B/C/D=1-244.
DR   PDB; 3D3W; X-ray; 1.87 A; A/B=1-244.
DR   PDBsum; 1PR9; -.
DR   PDBsum; 1WNT; -.
DR   PDBsum; 3D3W; -.
DR   ProteinModelPortal; Q7Z4W1; -.
DR   SMR; Q7Z4W1; -.
DR   BioGrid; 119357; 16.
DR   IntAct; Q7Z4W1; 5.
DR   STRING; 9606.ENSP00000303356; -.
DR   ChEMBL; CHEMBL2314; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB02831; Dihydrogenphosphate Ion.
DR   DrugBank; DB02325; Isopropyl Alcohol.
DR   iPTMnet; Q7Z4W1; -.
DR   PhosphoSitePlus; Q7Z4W1; -.
DR   BioMuta; DCXR; -.
DR   DMDM; 50400451; -.
DR   REPRODUCTION-2DPAGE; IPI00448095; -.
DR   EPD; Q7Z4W1; -.
DR   MaxQB; Q7Z4W1; -.
DR   PaxDb; Q7Z4W1; -.
DR   PeptideAtlas; Q7Z4W1; -.
DR   PRIDE; Q7Z4W1; -.
DR   DNASU; 51181; -.
DR   Ensembl; ENST00000306869; ENSP00000303356; ENSG00000169738.
DR   GeneID; 51181; -.
DR   KEGG; hsa:51181; -.
DR   UCSC; uc002kdg.4; human.
DR   CTD; 51181; -.
DR   DisGeNET; 51181; -.
DR   GeneCards; DCXR; -.
DR   HGNC; HGNC:18985; DCXR.
DR   HPA; HPA023371; -.
DR   HPA; HPA023863; -.
DR   MalaCards; DCXR; -.
DR   MIM; 260800; phenotype.
DR   MIM; 608347; gene.
DR   neXtProt; NX_Q7Z4W1; -.
DR   OpenTargets; ENSG00000169738; -.
DR   Orphanet; 2843; Pentosuria.
DR   PharmGKB; PA38772; -.
DR   eggNOG; KOG1207; Eukaryota.
DR   eggNOG; ENOG410XQCY; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG105069; -.
DR   InParanoid; Q7Z4W1; -.
DR   KO; K03331; -.
DR   OMA; WSDPCKA; -.
DR   OrthoDB; EOG091G0GV2; -.
DR   PhylomeDB; Q7Z4W1; -.
DR   TreeFam; TF313841; -.
DR   BRENDA; 1.1.1.10; 2681.
DR   Reactome; R-HSA-5661270; Catabolism of glucuronate to xylulose-5-phosphate.
DR   SABIO-RK; Q7Z4W1; -.
DR   ChiTaRS; DCXR; human.
DR   EvolutionaryTrace; Q7Z4W1; -.
DR   GenomeRNAi; 51181; -.
DR   PRO; PR:Q7Z4W1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000169738; -.
DR   CleanEx; HS_DCXR; -.
DR   ExpressionAtlas; Q7Z4W1; baseline and differential.
DR   Genevisible; Q7Z4W1; HS.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0050038; F:L-xylulose reductase (NADP+) activity; IDA:UniProtKB.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB.
DR   GO; GO:0042732; P:D-xylose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006006; P:glucose metabolic process; IDA:UniProtKB.
DR   GO; GO:0019640; P:glucuronate catabolic process to xylulose 5-phosphate; TAS:Reactome.
DR   GO; GO:0006739; P:NADP metabolic process; IEA:Ensembl.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0005997; P:xylulose metabolic process; IDA:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Carbohydrate metabolism; Complete proteome;
KW   Direct protein sequencing; Glucose metabolism; Membrane; Methylation;
KW   NADP; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Xylose metabolism.
FT   CHAIN         1    244       L-xylulose reductase.
FT                                /FTId=PRO_0000054554.
FT   NP_BIND      11     40       NADP. {ECO:0000269|PubMed:15103634}.
FT   ACT_SITE    149    149       Proton acceptor.
FT   BINDING     136    136       Substrate. {ECO:0000269|PubMed:15103634}.
FT   BINDING     153    153       NADP. {ECO:0000269|PubMed:15103634}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES      21     21       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES      46     46       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MUTAGEN     107    107       N->L,D: Loss of function. Probably due to
FT                                defects in formation of the active site
FT                                and binding of coenzyme.
FT                                {ECO:0000269|PubMed:15103634}.
FT   CONFLICT    118    118       V -> A (in Ref. 5; AAP97273).
FT                                {ECO:0000305}.
FT   CONFLICT    239    239       G -> R (in Ref. 1). {ECO:0000305}.
FT   STRAND        9     14       {ECO:0000244|PDB:1PR9}.
FT   HELIX        18     29       {ECO:0000244|PDB:1PR9}.
FT   STRAND       33     39       {ECO:0000244|PDB:1PR9}.
FT   HELIX        41     50       {ECO:0000244|PDB:1PR9}.
FT   STRAND       55     58       {ECO:0000244|PDB:1PR9}.
FT   HELIX        64     71       {ECO:0000244|PDB:1PR9}.
FT   STRAND       79     82       {ECO:0000244|PDB:1PR9}.
FT   HELIX        92     94       {ECO:0000244|PDB:1PR9}.
FT   HELIX        97    107       {ECO:0000244|PDB:1PR9}.
FT   HELIX       109    125       {ECO:0000244|PDB:1PR9}.
FT   STRAND      129    134       {ECO:0000244|PDB:1PR9}.
FT   HELIX       137    139       {ECO:0000244|PDB:1PR9}.
FT   HELIX       147    167       {ECO:0000244|PDB:1PR9}.
FT   HELIX       168    170       {ECO:0000244|PDB:1PR9}.
FT   STRAND      172    179       {ECO:0000244|PDB:1PR9}.
FT   HELIX       185    188       {ECO:0000244|PDB:1PR9}.
FT   HELIX       194    201       {ECO:0000244|PDB:1PR9}.
FT   HELIX       212    223       {ECO:0000244|PDB:1PR9}.
FT   HELIX       225    227       {ECO:0000244|PDB:1PR9}.
FT   STRAND      234    238       {ECO:0000244|PDB:1PR9}.
FT   HELIX       241    243       {ECO:0000244|PDB:1PR9}.
SQ   SEQUENCE   244 AA;  25913 MW;  F82B7A178D46EAA5 CRC64;
     MELFLAGRRV LVTGAGKGIG RGTVQALHAT GARVVAVSRT QADLDSLVRE CPGIEPVCVD
     LGDWEATERA LGSVGPVDLL VNNAAVALLQ PFLEVTKEAF DRSFEVNLRA VIQVSQIVAR
     GLIARGVPGA IVNVSSQCSQ RAVTNHSVYC STKGALDMLT KVMALELGPH KIRVNAVNPT
     VVMTSMGQAT WSDPHKAKTM LNRIPLGKFA EVEHVVNAIL FLLSDRSGMT TGSTLPVEGG
     FWAC
//
